Leah M. Mayo, Ph.D.
 

Leah M. Mayo PhD

As a human behavioral pharmacologist, my goal is to use pharmacology to provide a mechanistic understanding of stress and affective processing and their contributions to mental health. Our group is particularly interested in exploring novel cannabinoid- and psychedelic-based pharmacotherapies for stress-related psychiatric disorders.

We combine behavior, pharmacology, psychophysiology, and neuroimaging methods, and have a strong translational focus, basing much of our work in healthy and clinical human populations on findings from preclinical animal models.

In the Fall of 2022, I will be the incoming Parker Chair in Psychedelics Research at the Department of Psychiatry, the Hotchkiss Brain Institute and the Mathison Centre for Mental Health Research and Education at the University Calgary (see below for more information).

If you are interested in joining our team -

please get in touch!


FOLLOW ME

 
 
Mayo+072217+120354.jpg
 
 

Recent News

Feb 2023

Lots of excitement as we set up the new lab here in Calgary:

Feb 5th article about psychedelics from the Globe & Mail

Coverage from The Edmonton Journal on Alberta’s new psychedelic regulations

Reporting from the CBC on psychedelic-assisted psychotherapy

October 2022

I recently had the privilege of joining the Scientific Advisory board for PharmAla Biotech

June 2022

HUGE NEWS - We are moving to Canada!

I will join the University of Calgary’s Hotchkiss Brain Institute, Mathison Centre for Mental Health Research and Education, and Department of Psychiatry as the inaugural Parker Research Chair in Psychedelics!

This is an amazing opportunity to contribute to evidence-based clinical medicine, made possible by a generous ednowment from Jim Parker. We will soon advertise positions for postdocs, students, & other staff, but please get in touch if interested. See below for more coverage about the position and our work.

UCalgary News Story

Article on The Growth Op

As It Happens June 2 Episode on CBC Radio

Avenue Magazine (pg. 38)

December 2021

The lab recently attended the [virtual] Society for Social Neuroscience conference, where postdoc Connor Haggarty chaired and presented in a symposium on social touch and trauma exposure, and I received the Early Career Award. See more details here.

April 2021

Our new paper out in Molecular Psychiatry, led by my colleague Dr. Andrea Capusan, explored the link between childhood maltreatment and substance use disorders using a novel population-based approach.

We are currently following up this study by inviting these patient populations into the lab to assess laboratory measures of stress and affective processing - stay tuned!

February 2021

Our recent paper on endocannabinoid modulation in humans has earned a share of the 2021 Somerfeld-Ziskind Research Award from the Society for Biological Psychiatry. I am so grateful to my colleagues and collaborators who made this project possible!

Read a short interview with LiU news here

and check out the [virtual] acceptance speech here

September 2020

Good news in a challenging year: I received the Young Scientist Award from the European Behavioral Pharmacology Society!

EBPS is one of my absolute favorite conferences (and the reason I first visited Europe back in 2013) so this is such a huge honor. Hoping for an in-person meeting next summer in Maastricht!

May 2020

I have officially started as an assistant professor within the Center for Social and Affective Neuroscience at Linköping University and cannot wait for all the exciting science to get rolling!

Nov 2019

TV4 recently visited us to learn more about our research regarding the endocannabinoid system and PTSD. The video is in Swedish, except for when I speak ;)

Oct 2019

BIG NEWS: I received a Starting Grant from the Swedish Research Council! (LiU press release)

This 4-year, 6 million SEK grant will allow me to start my independent research group at Linköping University, exploring the role of the endocannabinoid system in PTSD and other stress-related psychiatric disorders.

Stay tuned for hiring announcements!

Oct 2019

We were recently interviewed by PsyPost about our paper showing gender differences in the subjective and behavioral effects of methamphetamine in healthy humans.

Aug 2019

We are VERY excited that our new paper (link, PDF) is out in Biological Psychiatry, demonstrating the beneficial effects of pharmacological inhibition of FAAH to elevate anandamide in healthy humans…one step closer to a new pharmacotherapeutic option for PTSD!